Several reports have indicated that PHLPP1 is downregulated in metastatic and aggressive breast cancer cells when compared with the levels in normal cells [17,18], but the mechanism of this downregulation of PHLPP1 in these cancer cells is not well studied. Here, PHLPP1 is linked to breast carcinoma.